Small Cap📈 ASX: MAP
Microba Life Sciences Limited (ASX: MAP)
Published 30 June 2025Penny Stock Spotlight Report
Microba Life Sciences Limited
ASX:
MAP
Microba Life Sciences Ltd. engages in the provision of microbiome testing, supplements and analysis services as well as developing new pathology services, therapeutics, and diagnostics based on the human gut microbiome. It operates through the Testing Se
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
Penny Stock Spotlight Report
A$399.00
Already a subscriber?
Sign in to read this report.
Required subscription
Penny Stock Spotlight Report
Explore emerging ASX penny stock opportunities through weekly research focused on early-stage companies, growth catalysts, and high-risk, high-potential investment ideas.
- ✓ Exclusive Weekly Penny Stock Research
- ✓ Delivered Every Monday
- ✓ Risk Rating: High Risk, High Reward
- ✓ Full Historical Report Access
A$399.00A$1500.00/ 12 months
Risk:High
Subscribe Now →
